bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
2.660
+0.450 (20.36%)
At close: Apr 28, 2026, 4:00 PM EDT
2.640
-0.020 (-0.75%)
After-hours: Apr 28, 2026, 4:27 PM EDT
bioAffinity Technologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 6.16 | 9.36 | 2.53 | 0 | - | |
| Revenue Growth (YoY) | -34.18% | 269.68% | 52627.44% | - | - | |
| Cost of Revenue | 4.23 | 5.98 | 1.74 | 0 | - | |
| Gross Profit | 1.94 | 3.38 | 0.79 | 0 | - | |
| Selling, General & Admin | 9.91 | 9.94 | 6.79 | 2.48 | 1.07 | |
| Research & Development | 2.09 | 1.78 | 1.72 | 1.52 | 1.14 | |
| Operating Expenses | 12.51 | 12.33 | 8.76 | 4.02 | 2.21 | |
| Operating Income | -10.57 | -8.95 | -7.97 | -4.01 | -2.21 | |
| Interest Expense | -0.04 | -0.09 | -0.04 | -2.53 | -1 | |
| Interest & Investment Income | 0.02 | 0.02 | 0.12 | 0.05 | 0 | |
| Other Non Operating Income (Expenses) | -4.27 | 0 | -0.03 | -1.87 | -3.36 | |
| EBT Excluding Unusual Items | -14.87 | -9.03 | -7.92 | -8.36 | -6.56 | |
| Other Unusual Items | - | - | - | 0.21 | 0.24 | |
| Pretax Income | -14.87 | -9.03 | -7.92 | -8.15 | -6.32 | |
| Income Tax Expense | 0.04 | 0.01 | 0.02 | 0 | 0 | |
| Net Income | -14.91 | -9.04 | -7.94 | -8.15 | -6.33 | |
| Net Income to Common | -14.91 | -9.04 | -7.94 | -8.15 | -6.33 | |
| Shares Outstanding (Basic) | 2 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 2 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 325.83% | 38.61% | 94.43% | 68.17% | 0.02% | |
| EPS (Basic) | -8.66 | -22.37 | -27.22 | -54.37 | -70.94 | |
| EPS (Diluted) | -8.66 | -22.37 | -27.22 | -54.37 | -70.94 | |
| Free Cash Flow | -9.39 | -7.34 | -6.06 | -4.29 | -2.05 | |
| Free Cash Flow Per Share | -5.46 | -18.17 | -20.79 | -28.61 | -22.98 | |
| Gross Margin | 31.41% | 36.09% | 31.26% | 90.28% | - | |
| Operating Margin | -171.58% | -95.64% | -314.84% | -83511.51% | - | |
| Profit Margin | -241.96% | -96.56% | -313.41% | -169771.25% | - | |
| Free Cash Flow Margin | -152.38% | -78.44% | -239.32% | -89336.50% | - | |
| EBITDA | -10.07 | -8.35 | -7.72 | -4 | -2.2 | |
| EBITDA Margin | -163.38% | -89.17% | - | - | - | |
| D&A For EBITDA | 0.5 | 0.61 | 0.25 | 0.01 | 0 | |
| EBIT | -10.57 | -8.95 | -7.97 | -4.01 | -2.21 | |
| EBIT Margin | -171.58% | -95.64% | - | - | - | |
| Advertising Expenses | 0.34 | 0.27 | 0.09 | 0.04 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.